Table 3.
The potential diagnostic biomarkers of any two groups of CK, SK, and NC
No | Compoundsa |
CK vs NC |
SK vs NC |
CK vs SK |
|||
---|---|---|---|---|---|---|---|
LR+b | AUCc | LR+b | AUCc | LR+b | AUCc | ||
1 |
GA |
0.25 |
0.122 |
0.38 |
0.176 |
|
|
2 |
L-ala |
0.06 |
0.149 |
|
|
0.30 |
0.216 |
3 |
L-ser |
|
|
|
|
0.36 |
0.240 |
4 |
GLCA |
0.19 |
0.153 |
0.05 |
0.19 |
|
|
5 |
Erythritol |
0.28 |
0.161 |
|
|
|
|
6 |
Ribitol |
0.26 |
0.171 |
|
|
|
|
7 |
Glc |
0.24 |
0.176 |
1.07 |
0.259 |
|
|
8 |
LA |
0.07 |
0.178 |
0.18 |
0.199 |
|
|
9 |
Gal |
0.34 |
0.184 |
0.42 |
0.22 |
|
|
10 |
GABA |
0.15 |
0.221 |
|
|
0.26 |
0.261 |
11 |
DHB |
|
|
|
|
0.36 |
0.257 |
12 |
THB |
0.38 |
0.231 |
|
|
|
|
13 |
pGlu |
0.47 |
0.269 |
|
|
|
|
14 |
MMA |
|
|
1.01 |
0.283 |
|
|
15 |
Melibiose |
1.05 |
0.277 |
|
|
|
|
16 |
Citrate |
|
|
|
|
0.42 |
0.281 |
17 |
3HV |
|
|
2.32 |
0.79 |
|
|
18 |
AABA |
|
|
11.80 |
0.79 |
|
|
19 |
L-leu |
1.89 |
0.638 |
|
|
|
|
20 |
Xylitol |
3.16 |
0.752 |
|
|
|
|
21 |
Gly |
2.33 |
0.76 |
7.90 |
0.837 |
|
|
22 |
2Me3HB |
3.60 |
0.764 |
|
|
|
|
23 |
AMA |
2.57 |
0.773 |
3.09 |
0.822 |
|
|
24 |
AABA |
1.05 |
0.773 |
|
|
|
|
25 |
αTP |
2.37 |
0.783 |
|
|
|
|
26 |
L-ile |
3.16 |
0.814 |
3.32 |
0.827 |
|
|
27 |
HMG |
4.07 |
0.848 |
|
|
|
|
28 |
Sitosterol |
3.00 |
0.88 |
|
|
1.91 |
0.741 |
29 |
PA |
6.35 |
0.897 |
5.29 |
0.838 |
|
|
30 |
C-9-HA |
3.81 |
0.909 |
2.75 |
0.842 |
|
|
31 |
Hep |
7.02 |
0.911 |
5.15 |
0.866 |
|
|
32 |
MA |
6.01 |
0.913 |
3.21 |
0.845 |
|
|
33 |
SA |
6.35 |
0.913 |
3.44 |
0.842 |
|
|
34 |
2PC |
4.97 |
0.918 |
7.78 |
0.923 |
|
|
35 |
T-9-OA |
4.21 |
0.924 |
3.58 |
0.868 |
|
|
36 |
3HV |
9.09 |
0.95 |
|
|
2.38 |
0.764 |
37 | BHBA | 10.22 | 0.977 | 8.13 | 0.965 | 5.11 | 0.953 |
aAbbreviations of compounds’ name are same as Table 2.
b+LR, positive likelihood ratio.
cAUC, area under the curve. If AUC value is more than 7.00 or less than 0.30, compound is considered to be a potential diagnostic biomarker of disease.